ESCONDIDO, Calif.--(BUSINESS WIRE)--BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R.

This important study demonstrates that the transcription factor Chinmo is a master regulator that maintains larval growth and development as part of the metamorphic gene network in Drosophila. Chinmo ...